Financial Enhancement Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-300
Closed 333
2020
Q4
$0 Hold
300
﹤0.01% 329
2020
Q3
$1K Hold
300
﹤0.01% 255
2020
Q2
$1K Buy
300
+250
+500% +$833 ﹤0.01% 241
2020
Q1
$0 Hold
50
﹤0.01% 321
2019
Q4
$0 Buy
+50
New ﹤0.01% 312